Search research articles
Contact Us
Filters
Showing results (41-50 of 106) with videos related to
Page
of 11
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
December 31, 2013
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Barbara Romano, Francesca Borrelli, Ester Pagano, et al.
Human Mutation
|
October 15, 2019
Disease-associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue-specific activity of the cannabinoid-1 receptor gene promoter; implications for cannabinoid pharmacogenetics
Elizabeth A Hay, Philip Cowie, Andrew R McEwan, et al.
European Journal of Pharmacology
|
March 23, 2004
6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
Adèle Thomas, Ruth A Ross, Bijali Saha, et al.
Psychoneuroendocrinology
|
August 25, 2019
Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour
Elizabeth A Hay, Andrew McEwan, Dana Wilson, et al.
Journal of Neuroscience Research
|
June 16, 2011
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
Onintza Sagredo, M Ruth Pazos, Valentina Satta, et al.
Progress in Lipid Research
|
October 30, 2012
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
Iain Brown, Maria G Cascio, Dino Rotondo, et al.
Journal of Medicinal Chemistry
|
July 11, 2003
Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'
Demetris P Papahatjis, Spyros P Nikas, Therapia Kourouli, et al.
Experimental Neurology
|
August 6, 2015
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Ross B Mounsey, Sarah Mustafa, Lianne Robinson, et al.
British Journal of Pharmacology
|
October 20, 2004
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol
Nazdar Ghafouri, Gunnar Tiger, Raj K Razdan, et al.
Psychopharmacology
|
December 1, 2007
Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats
Lianne Robinson, Susan McKillop-Smith, Nicola L Ross, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 106) with videos related to
Sort By:
Page
of 11
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
December 31, 2013
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Barbara Romano, Francesca Borrelli, Ester Pagano, et al.
Human Mutation
|
October 15, 2019
Disease-associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue-specific activity of the cannabinoid-1 receptor gene promoter; implications for cannabinoid pharmacogenetics
Elizabeth A Hay, Philip Cowie, Andrew R McEwan, et al.
European Journal of Pharmacology
|
March 23, 2004
6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
Adèle Thomas, Ruth A Ross, Bijali Saha, et al.
Psychoneuroendocrinology
|
August 25, 2019
Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour
Elizabeth A Hay, Andrew McEwan, Dana Wilson, et al.
Journal of Neuroscience Research
|
June 16, 2011
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
Onintza Sagredo, M Ruth Pazos, Valentina Satta, et al.
Progress in Lipid Research
|
October 30, 2012
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
Iain Brown, Maria G Cascio, Dino Rotondo, et al.
Journal of Medicinal Chemistry
|
July 11, 2003
Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'
Demetris P Papahatjis, Spyros P Nikas, Therapia Kourouli, et al.
Experimental Neurology
|
August 6, 2015
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Ross B Mounsey, Sarah Mustafa, Lianne Robinson, et al.
British Journal of Pharmacology
|
October 20, 2004
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol
Nazdar Ghafouri, Gunnar Tiger, Raj K Razdan, et al.
Psychopharmacology
|
December 1, 2007
Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats
Lianne Robinson, Susan McKillop-Smith, Nicola L Ross, et al.
Page
of 11